AI Verdict
GTBIF has stronger fundamentals based on our AI analysis.
GTBP vs GTBIF Fundamental Comparison
| Metric | GTBP | GTBIF |
|---|---|---|
| Revenue | $0.0 | $1.2B |
| Net Income | $-28.4M | $114.2M |
| Net Margin | N/A | 9.7% |
| ROE | -490.0% | 6.0% |
| ROA | -349.8% | 4.1% |
| Current Ratio | 3.50x | 3.26x |
| Debt/Equity | 0.00x | 0.13x |
| EPS | $-6.68 | $0.48 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
GTBP vs GTBIF: Frequently Asked Questions
Is GTBP or GTBIF a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), GTBIF has stronger fundamentals. GTBP is rated STRONG SELL (83% confidence) while GTBIF is rated BUY (74% confidence). This is not investment advice.
How does GTBP compare to GTBIF fundamentally?
GT Biopharma, Inc. has ROE of -490.0% vs Green Thumb Industries Inc.'s 6.0%. Net margins are N/A vs 9.7% respectively.
Which stock pays higher dividends, GTBP or GTBIF?
GTBP has a dividend yield of N/A or no dividend while GTBIF has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in GTBP or GTBIF for long term?
For long-term investing, consider that GTBP has STRONG SELL rating with 83% confidence, while GTBIF has BUY rating with 74% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about GTBP vs GTBIF?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For GTBP vs GTBIF, the AI consensus favors GTBIF based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.